Patent · US Active

Use of a lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance

US10022407B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignees

Compagnie Gervais Danone · FR
Tufts University · US

Inventors

Jian Shen · Nanhu, CN
Jingjing Wang · Shanghai, CN
Liping Zhao · Cambridge, US
Martin Saul Obin · Newton, US
Muriel Derrien · Les Ulis, FR
Emilie Rocher · Massy, FR
Johan Van Hylckama Vlieg · Marly-le-Roi, FR

Key dates

Filing date	Nov 12, 2012
Grant date	Jul 17, 2018
Priority date	—
Expiry date	Dec 27, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/225
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are the use of Lactobacillus rhamnosus strain CNCM I-3690 for reducing diet-induced weight gain and/or diet-induced insulin resistance, and treating disorders resulting therefrom, such as overweight, obesity and obesity-related disorders in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.